DGCI gives a go-ahead for Phase III Sputnik Light trials
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
Visby Medical’s instrument-free PCR test to detect the SARS-CoV-2 virus can now be used to pool up to five patient samples using a single test
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
The three-dose vaccine approved for EUA contains 2mg for each dose, whereas the two-dose plan will have 3mg in each dose.
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
HTL will build, validate and operate a botulinum manufacturing facility in the US
Subscribe To Our Newsletter & Stay Updated